| | Editorials Antibodies against Pseudomonas
aeruginosa in patients with bronchiectasis: helpful or harmful? N HOIBY Thorax. 2001 September; 56(9): 667–668. doi: 10.1136/thorax.56.9.667.PMCID: PMC1746143 Free access to Thorax for
low income countries A WILLIAMSON, A KNOX, and J BRITTON Thorax. 2001 September; 56(9): 668. doi: 10.1136/thorax.56.9.668.PMCID: PMC1746147 Original Articles Anti-Pseudomonas aeruginosa antibody
detection in patients with bronchiectasis without cystic fibrosis E Caballero, M Drobnic, M Perez, J Manresa, A Ferrer, and R Orriols Thorax. 2001 September; 56(9): 669–674. doi: 10.1136/thorax.56.9.669.PMCID: PMC1746128 Effects of inhaled salbutamol in exercising non-asthmatic
athletes C Goubault, M Perault, E Leleu, S Bouquet, P Legros, B Vandel, and A Denjean Thorax. 2001 September; 56(9): 675–679. doi: 10.1136/thorax.56.9.675.PMCID: PMC1746141 Airway function at one year: association with premorbid airway
function, wheezing, and maternal smoking C Dezateux, J Stocks, A Wade, I Dundas, and M Fletcher Thorax. 2001 September; 56(9): 680–686. doi: 10.1136/thorax.56.9.680.PMCID: PMC1746127 Changing patterns of hospital admission for asthma, 1981-97 D Morrison and P McLoone Thorax. 2001 September; 56(9): 687–690. doi: 10.1136/thorax.56.9.687.PMCID: PMC1746129 Reference values of interrupter respiratory resistance in healthy
preschool white children E Lombardi, P Sly, G Concutelli, E Novembre, G Veneruso, G Frongia, R Bernardini, and A Vierucci Thorax. 2001 September; 56(9): 691–695. doi: 10.1136/thorax.56.9.691.PMCID: PMC1746135 Enhanced survival of lung granulocytes in an animal model of
asthma: evidence for a role of GM-CSF activated STAT5 signalling
pathway R Turlej, L Fievez, C Sandersen, S Dogne, N Kirschvink, P Lekeux, and F Bureau Thorax. 2001 September; 56(9): 696–702. doi: 10.1136/thorax.56.9.696.PMCID: PMC1746130 Smoking cessation, decline in pulmonary function and total
mortality: a 30 year follow up study among the Finnish cohorts of the
Seven Countries Study M Pelkonen, I Notkola, H Tukiainen, M Tervahauta, J Tuomilehto, and A Nissinen Thorax. 2001 September; 56(9): 703–707. doi: 10.1136/thorax.56.9.703.PMCID: PMC1746131 Non-invasive ventilation in acute exacerbations of chronic
obstructive pulmonary disease: long term survival and predictors of
in-hospital outcome P Plant, J Owen, and M Elliott Thorax. 2001 September; 56(9): 708–712. doi: 10.1136/thorax.56.9.708.PMCID: PMC1746126 Alternative methods for assessing bronchodilator reversibility in
chronic obstructive pulmonary disease J Hadcroft and P Calverley Thorax. 2001 September; 56(9): 713–720. doi: 10.1136/thorax.56.9.713.PMCID: PMC1746134 Systemic anti-inflammatory mediators in COPD: increase in soluble
interleukin 1 receptor II during treatment of exacerbations M Dentener, E Creutzberg, A Schols, A Mantovani, V van`t, W Buurman, and E Wouters Thorax. 2001 September; 56(9): 721–726. doi: 10.1136/thorax.56.9.721.PMCID: PMC1746133 Continuous positive airway pressure for sleep apnoea/hypopnoea
syndrome: usefulness of a 2 week trial to identify factors associated
with long term use G Popescu, M Latham, V Allgar, and M Elliott Thorax. 2001 September; 56(9): 727–733. doi: 10.1136/thorax.56.9.727.PMCID: PMC1746132 Short Paper Aerosolised iloprost improves pulmonary haemodynamics in patients
with primary pulmonary hypertension receiving continuous epoprostenol
treatment V Petkov, R Ziesche, W Mosgoeller, P Schenk, K Vonbank, L Stiebellehner, M Raderer, C. Brunner, M Kneussl, and L Block Thorax. 2001 September; 56(9): 734–736. doi: 10.1136/thorax.56.9.734.PMCID: PMC1746148 Case Report Pulmonary hypertension, interstitial lung fibrosis, and lung iron
deposition in thalassaemia major E Zakynthinos, T Vassilakopoulos, P Kaltsas, E Malagari, Z Daniil, C Roussos, and S Zakynthinos Thorax. 2001 September; 56(9): 737–739. doi: 10.1136/thorax.56.9.737.PMCID: PMC1746136 Letters to the Editor COPD exacerbations M HAGGERTY Thorax. 2001 September; 56(9): 740. doi: 10.1136/thorax.56.9.740.PMCID: PMC1746137 CFC transition D BROCKLEBANK and J WRIGHT Thorax. 2001 September; 56(9): 740. doi: 10.1136/thorax.56.9.740a.PMCID: PMC1746139 Hyperventilation syndrome D INNOCENTI Thorax. 2001 September; 56(9): 740. doi: 10.1136/thorax.56.9.740b.PMCID: PMC1746142 Obesity and lung function D AHMAD, W MORGAN, and L SCHACHTER Thorax. 2001 September; 56(9): 740–741. doi: 10.1136/thorax.56.9.740c.PMCID: PMC1746146 BCG re-vaccination P GRIME and P. ORMEROD Thorax. 2001 September; 56(9): 741–742. doi: 10.1136/thorax.56.9.741.PMCID: PMC1746140 Reliability of PEF diaries W ANEES, V HUGGINS, P BURGE, A KAMPS, R ROORDA, and P BRAND Thorax. 2001 September; 56(9): 742. doi: 10.1136/thorax.56.9.742.PMCID: PMC1746145 Lung cancer survival H SATOH, Y YAMASHITA, and K SEKIZAWA Thorax. 2001 September; 56(9): 742. doi: 10.1136/thorax.56.9.742a.PMCID: PMC1746125 Journal Matter Original table of contents page |